| 英文名稱 | Lapatinib (GW572016; GW2016,Tykerb, Tyverb) | 
|---|---|
| 中文名稱 | 拉帕替尼堿 | 拉帕替尼 | 
| CAS號 | 231277-92-2 | 
| 分子式 | C29H26ClFN4O4S | 
| 分子量 | 581.06 | 
| 外觀 | Light yellow to yellow powder | 
| 儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). | 
| 英文名稱 | Lapatinib (GW572016; GW2016,Tykerb, Tyverb) | 
|---|---|
| 中文名稱 | 拉帕替尼堿 | 拉帕替尼 | 
| CAS號 | 231277-92-2 | 
| 分子式 | C29H26ClFN4O4S | 
| 分子量 | 581.06 | 
| 外觀 | Light yellow to yellow powder | 
| 儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). | 
Lapatinib (formerly GW572016, trade namesTykerb&Tyverb), usually used in the Ditosylate form, is a potent, orally bioavailable dual EGFR/ErbB2 inhibitor with potential anticancer activity.